Foghorn Therapeutics (FHTX) Retained Earnings: 2020-2025
Historic Retained Earnings for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to -$610.8 million.
- Foghorn Therapeutics' Retained Earnings fell 13.38% to -$610.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$610.8 million, marking a year-over-year decrease of 13.38%. This contributed to the annual value of -$558.2 million for FY2024, which is 18.37% down from last year.
- According to the latest figures from Q3 2025, Foghorn Therapeutics' Retained Earnings is -$610.8 million, which was down 2.66% from -$595.0 million recorded in Q2 2025.
- Foghorn Therapeutics' Retained Earnings' 5-year high stood at -$185.9 million during Q1 2021, with a 5-year trough of -$610.8 million in Q3 2025.
- Its 3-year average for Retained Earnings is -$513.8 million, with a median of -$519.6 million in 2024.
- Data for Foghorn Therapeutics' Retained Earnings shows a maximum YoY tumbled of 65.37% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Foghorn Therapeutics' Retained Earnings stood at -$264.3 million in 2021, then tumbled by 41.20% to -$373.1 million in 2022, then dropped by 26.38% to -$471.6 million in 2023, then dropped by 18.37% to -$558.2 million in 2024, then dropped by 13.38% to -$610.8 million in 2025.
- Its Retained Earnings was -$610.8 million in Q3 2025, compared to -$595.0 million in Q2 2025 and -$577.0 million in Q1 2025.